Providence researchers conducted over 2400 studies in 2023, according to the Providence Research Network Annual Report, released on May 20th to coincide with Clinical Trials Day
View the report online or read on for more information.
Providence researchers conducted over 2400 studies, $128M in research activities and newly enrolled over 2800 patients in clinical trials during 2023, according to the new 2023 Providence Research Network Annual Report. The report features a selection of research success stories and highlights from across the seven-state Providence family of organizations, including:
- The evaluation of a promising immunotherapy for non-small cell lung cancer at the Providence Cancer Institute of Oregon
- The study of clinical factors of early-onset colon cancer at Saint John’s Cancer Institute in Southern California
- The expansion of a minimally invasive treatment for heart valve disease at the Swedish Heart & Vascular Institute in Washington State
- Multiple initiatives bringing clinical research to historically underserved communities
- Ongoing efforts at multiple sites to make the promise of genomic medicine accessible to more patients
These and other stories in the report showcase how clinical trials and other studies conducted at Providence are advancing care for today’s most pervasive and challenging diseases, making new treatments available to more patients, and improving health outcomes for all.
“The stories in this report exemplify some of the many ways Providence is shaping the future of health care,” explains Ari Robicsek, chief analytics and research officer. “We are grateful and blessed for the brilliant and dedicated minds across our organization who are championing research to help our patients achieve optimal health outcomes today and tomorrow.”
The report was released on Clinical Trials Day 2024, celebrated annually on May 20 to honor the contributions of clinical research professionals who dedicate themselves to improving health care and developing life-saving treatments.
